Shanghai, China

Jianren Gu

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 3.8

ph-index = 3

Forward Citations = 27(Granted Patents)


Company Filing History:


Years Active: 2002-2020

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Jianren Gu

Introduction

Jianren Gu is a prominent inventor based in Shanghai, China, known for his significant contributions to the field of biomedical engineering. With a total of 10 patents to his name, Gu has made remarkable advancements in cancer treatment and immunotherapy.

Latest Patents

Among his latest patents is the invention of chimeric antigen receptors targeting GPC3. This innovation involves a nucleic acid encoding a chimeric antigen receptor expressed on the surface of T lymphocytes. The receptor comprises an extracellular binding domain, a transmembrane region, and an intracellular signaling domain. The extracellular binding domain includes a single chain antibody, scFv(GPC3), which specifically recognizes the C-terminal epitope of GPC3. Another notable patent is the development of a human epidermal growth factor receptor variant lacking an exon. This variant, known as de4 EGFR protein, promotes tumor cell invasion and metastasis, and it is produced using recombination technology.

Career Highlights

Jianren Gu has worked with esteemed organizations such as the Shanghai Cancer Institute and Carsgen Therapeutics Limited. His work in these institutions has been pivotal in advancing cancer research and developing innovative therapies.

Collaborations

Gu has collaborated with notable colleagues in his field, including Shengli Yang and Zonghai Li. Their combined expertise has contributed to the success of various research projects and innovations.

Conclusion

Jianren Gu's contributions to the field of biomedical engineering and cancer treatment through his patents and collaborations highlight his role as a leading inventor. His work continues to influence advancements in immunotherapy and cancer research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…